Extensive psoriasis induced by pegylated interferon: a case report
2007
Psoriasis Induced by Pegylated Interferon: A Case Report
Sample size: 1
publication
Evidence: low
Author Information
Author(s): Citro Vincenzo, Fristachi Raffaele, Tarantino Giovanni
Primary Institution: U.O.C. of General Medicine, Hepatological Unit, 'Mauro Scarlato' Hospital, Scafati (SA), Italy
Conclusion
The patient's psoriasis worsened during treatment with Pegylated Interferon but completely receded after therapy was stopped.
Supporting Evidence
- The patient had no history of psoriasis before treatment.
- Psoriasis developed during the third month of Pegylated Interferon therapy.
- The psoriasis worsened to over 75% of body involvement during treatment.
- The patient's liver enzyme levels normalized during the treatment.
- Psoriasis completely receded one month after stopping the therapy.
Takeaway
A woman treated for hepatitis C developed psoriasis while on medication, but it went away completely after she finished her treatment.
Methodology
The patient was treated with Pegylated Interferon and Ribavirin for 24 weeks, with monitoring of liver enzyme levels and viral load.
Limitations
This is a single case report, limiting the generalizability of the findings.
Participant Demographics
50-year-old woman with chronic hepatitis C.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website